However, there are differences between the results of the present study and a report by Zhang et al. which demonstrated that higher ratio of CD8+/ Treg was significantly associated with poor overall survival and progression-free survival in early nasopharyngeal carcinoma stage patients (41). The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.